Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Mizuta S, Sawa M, Tsurumi H, Matsumoto K, Miyao K, Hara T, Takahashi T, Sakemura R, Kojima H, Kohno A, Oba MS, Morita S, Sakamoto J, Emi N.

Int J Clin Oncol. 2018 May 29. doi: 10.1007/s10147-018-1300-9. [Epub ahead of print]

PMID:
29845477
2.

Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs.

Miyao K, Terakura S, Okuno S, Julamanee J, Watanabe K, Hamana H, Kishi H, Sakemura R, Koyama D, Goto T, Nishida T, Murata M, Kiyoi H.

Cancer Immunol Res. 2018 Jun;6(6):733-744. doi: 10.1158/2326-6066.CIR-17-0538. Epub 2018 Apr 13.

PMID:
29653982
3.

High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype.

Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Julamanee J, Takagi E, Hirano D, Miyao K, Sakemura R, Goto T, Hayakawa F, Seto A, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H.

PLoS One. 2017 Sep 25;12(9):e0185213. doi: 10.1371/journal.pone.0185213. eCollection 2017.

4.

Downregulation of cytochrome c oxidase 1 induced radioresistance in esophageal squamous cell carcinoma.

Takesue T, Kawakubo H, Hayashida T, Tsutsui M, Miyao K, Fukuda K, Nakamura R, Takahashi T, Wada N, Takeuchi H, Kitagawa Y.

Oncol Lett. 2017 Oct;14(4):4220-4224. doi: 10.3892/ol.2017.6699. Epub 2017 Aug 1.

5.

Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study.

Yokohata E, Kuwatsuka Y, Ohashi H, Terakura S, Kawashima N, Seto A, Kurahashi S, Ozawa Y, Goto T, Imahashi N, Nishida T, Miyao K, Sakemura R, Kato T, Sawa M, Kohno A, Sao H, Iida H, Kiyoi H, Naoe T, Miyamura K, Murata M.

Bone Marrow Transplant. 2017 Apr;52(4):612-614. doi: 10.1038/bmt.2016.323. Epub 2017 Jan 9. No abstract available.

PMID:
28067879
6.

The Efficacy of an Oral Elemental Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Morishita T, Tsushita N, Imai K, Sakai T, Miyao K, Sakemura R, Kato T, Niimi K, Ono Y, Sawa M.

Intern Med. 2016;55(24):3561-3569. Epub 2016 Dec 15.

7.

A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.

Miyao K, Sawa M, Kurata M, Suzuki R, Sakemura R, Sakai T, Kato T, Sahashi S, Tsushita N, Ozawa Y, Tsuzuki M, Kohno A, Adachi T, Watanabe K, Ohbayashi K, Inagaki Y, Atsuta Y, Emi N.

Int J Hematol. 2017 Jan;105(1):79-86. doi: 10.1007/s12185-016-2095-y. Epub 2016 Sep 30.

PMID:
27696283
8.

Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.

Goto T, Nishida T, Takagi E, Miyao K, Koyama D, Sakemura R, Hanajiri R, Watanabe K, Imahashi N, Terakura S, Murata M, Kiyoi H.

J Immunother. 2016 Oct;39(8):306-15. doi: 10.1097/CJI.0000000000000136.

PMID:
27548033
9.

A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration.

Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H.

Cancer Immunol Res. 2016 Aug;4(8):658-68. doi: 10.1158/2326-6066.CIR-16-0043. Epub 2016 Jun 21.

10.

Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies.

Miyao K, Sawa M, Kuwatsuka Y, Ozawa Y, Kato T, Kohno A, Sao H, Nishida T, Iida H, Naito K, Tsurumi H, Taji H, Mizuta S, Kusumoto S, Nakase K, Morishita Y, Kawashima N, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Bone Marrow Transplant. 2016 Jan;51(1):157-60. doi: 10.1038/bmt.2015.235. Epub 2015 Oct 5. No abstract available.

PMID:
26437064
11.

Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse.

Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Ann Hematol. 2015 Jul;94(7):1139-48. doi: 10.1007/s00277-015-2312-4. Epub 2015 Feb 15.

PMID:
25680895
12.

An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.

Zhussupova A, Hayashida T, Takahashi M, Miyao K, Okazaki H, Jinno H, Kitagawa Y.

PLoS One. 2014 Aug 19;9(8):e105285. doi: 10.1371/journal.pone.0105285. eCollection 2014.

13.

Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.

Miyao K, Sakemura R, Imai K, Sakai T, Tsushita N, Kato T, Niimi K, Ono Y, Sawa M.

Int J Hematol. 2014 Aug;100(2):152-8. doi: 10.1007/s12185-014-1608-9. Epub 2014 Jun 20.

PMID:
24947495
14.

Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance.

Takahashi M, Hayashida T, Okazaki H, Miyao K, Jinno H, Kitagawa Y.

Cancer Sci. 2014 Jun;105(6):675-82. doi: 10.1111/cas.12410. Epub 2014 May 2.

15.

Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.

Miyao K, Sakemura R, Sakai T, Tsushita N, Kato T, Niimi K, Ono Y, Sawa M.

Ann Hematol. 2014 Mar;93(3):529-30. doi: 10.1007/s00277-013-1835-9. Epub 2013 Jul 3. No abstract available.

PMID:
23820941
16.

Direct inhibition of the transforming growth factor-β pathway by protein-bound polysaccharide through inactivation of Smad2 signaling.

Ono Y, Hayashida T, Konagai A, Okazaki H, Miyao K, Kawachi S, Tanabe M, Shinoda M, Jinno H, Hasegawa H, Kitajima M, Kitagawa Y.

Cancer Sci. 2012 Feb;103(2):317-24. doi: 10.1111/j.1349-7006.2011.02133.x. Epub 2011 Nov 28.

17.

Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells.

Nishioku T, Matsumoto J, Dohgu S, Sumi N, Miyao K, Takata F, Shuto H, Yamauchi A, Kataoka Y.

J Pharmacol Sci. 2010;112(2):251-4. Epub 2010 Jan 30.

18.

Sex differences in human biological aging.

Nakamura E, Miyao K.

J Gerontol A Biol Sci Med Sci. 2008 Sep;63(9):936-44.

PMID:
18840798
19.

A method for identifying biomarkers of aging and constructing an index of biological age in humans.

Nakamura E, Miyao K.

J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1096-105.

PMID:
17921421
20.

Enhancement of stress tolerance in transgenic tobacco plants overexpressing Chlamydomonas glutathione peroxidase in chloroplasts or cytosol.

Yoshimura K, Miyao K, Gaber A, Takeda T, Kanaboshi H, Miyasaka H, Shigeoka S.

Plant J. 2004 Jan;37(1):21-33.

21.

Molecular characterization of glutathione peroxidase-like protein in halotolerant Chlamydomonas sp. W80.

Takeda T, Miyao K, Tamoi M, Kanaboshi H, Miyasaka H, Shigeoka S.

Physiol Plant. 2003 Apr;117(4):467-475.

PMID:
12675737
22.
23.

[Cholesterol embolism after percutaneous transluminal coronary angioplasty procedure: a case report].

Sakamoto T, Inoue N, Kunitomo K, Tokura T, Matsuo A, Inoue K, Fujita H, Miyao K, Ohta B, Kitamura M, Kato G.

J Cardiol. 2001 Feb;37(2):99-102. Japanese.

PMID:
11255701
24.

Fractional myocardial flow reserve (FFRmyo) after coronary intervention as a predictor of chronic restenosis.

Fujita H, Inoue N, Matsuo Y, Tokura T, Tanaka T, Ohta B, Matsumuro AM, Kuriyama T, Kitamura M, Miyao K.

J Invasive Cardiol. 1999 Sep;11(9):527-32.

PMID:
10745591
25.

[CABG after patch angioplasty of the left main coronary: artery report of a case].

Okamura T, Yokoyama S, Kou E, Inoue N, Kuriyama T, Matsumuro A, Fujita H, Tanaka T, Miyao K.

Kyobu Geka. 1998 Sep;51(10):845-8. Japanese.

PMID:
9757637
26.

Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.

Sasaki S, Nakagawa M, Nakata T, Endo N, Miyao K, Kitamura K, Fukuyama M, Kitani T, Yamada C.

Cardiology. 1997 Mar-Apr;88(2):160-5.

PMID:
9096917
27.

[Paroxysmal atrial fibrillation, paroxysmal atrial flutter, paroxysmal atrial fibrillo-flutter].

Kitamura M, Miyao K.

Ryoikibetsu Shokogun Shirizu. 1996;(12):523-5. Review. Japanese. No abstract available.

PMID:
9047528
28.
29.

[Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].

Terada K, Sugihara H, Shiga K, Ohtsuki K, Ito K, Taniguchi Y, Azuma A, Kohno Y, Miyao K, Nakagawa M.

J Cardiol. 1995 May;25(5):247-53. Japanese.

PMID:
7776194
30.

[Clinical significance of diffuse vasoconstriction of coronary arteries--a study using hyperventilation thallium-201 myocardial imaging].

Katamura M, Matsumuro A, Tamagaki S, Matoba S, Tsuji H, Kitamura M, Miyao K, Murata M.

Kaku Igaku. 1995 May;32(5):479-86. Japanese.

PMID:
7596068
31.

[Quantitative analysis of right ventricular overloading by 201Tl myocardial SPECT].

Taniguchi Y, Miyao K, Shima M, Kitamura M, Tsuji H, Shudo T, Sugihara H, Nakagawa M.

Kaku Igaku. 1993 Apr;30(4):371-6. Japanese.

PMID:
8315887
32.

[Fatigue of workers in computerized offices].

Miyao K.

Sangyo Igaku. 1992 Dec;34(7):650-1. Japanese. No abstract available.

PMID:
1300381
33.

[Apical sequestration in hypertrophic cardiomyopathy: its clinical features and pathophysiology].

Nakamura T, Matsubara K, Furukawa K, Kitamura H, Azuma A, Sugihara H, Katsume H, Nakagawa M, Miyao K, Kunishige H.

J Cardiol. 1991;21(2):361-74. Japanese.

PMID:
1841923
34.

[Classification of drug-release control systems and releasing profiles].

Miyao K.

Nihon Rinsho. 1989 Jun;47(6):1228-39. Japanese. No abstract available.

PMID:
2769984
35.

[Progress of drug infusion delivery systems].

Miyao K.

Nihon Rinsho. 1989 Jun;47(6):1268-77. Japanese. No abstract available.

PMID:
2671441
36.

Giant right atrial thrombus in Noonan syndrome combined with Eisenmenger's complex.

Tatsukawa H, Okajima Y, Furukawa K, Katsume H, Miyao K, Nakagawa M.

Chest. 1989 Apr;95(4):930-2.

PMID:
2924632
37.

Assessment of biological age by principal component analysis.

Nakamura E, Miyao K, Ozeki T.

Mech Ageing Dev. 1988 Dec;46(1-3):1-18.

PMID:
3226152
38.

[Assessment of left ventricular diastolic function during the cold pressor test (CPT) in normal subjects and patients with hypertension].

Tatsukawa H, Sugihara H, Okajima Y, Furukawa K, Adachi H, Mineo T, Katsume H, Miyao K, Ozeki T, Nakagawa M, et al.

Kaku Igaku. 1988 May;25(5):405-12. Japanese. No abstract available.

PMID:
3418977
39.

Verapamil induces protection of alloxan but not streptozotocin-induced diabetes in rats.

Katsumata K, Miyao K, Katsumata Y.

Horm Metab Res. 1988 Jan;20(1):65. No abstract available.

PMID:
2967238
40.

[Exercise renography with two-time injection of 99mTc-DTPA at a short interval--deconvolution analysis in normal subjects and patients with essential hypertension].

Kubota Y, Miyao K, Mineo T, Okajima Y, Kusuoka S, Murata M, Kotera H, Yamada C, Sugihara H, Adachi H, et al.

Kaku Igaku. 1986 Mar;23(3):267-71. Japanese. No abstract available.

PMID:
3525916
41.

[Diagnosis of acute myocardial infarction with 99mTc-hydroxymethylene diphosphonate (HMDP)].

Miyao K, Takahashi T, Kusuoka S, Kubota Y, Tanimura C, Mineo T, Ohmura M, Taniike K, Yamada C, Nakagawa H, et al.

Kaku Igaku. 1984 Feb;21(2):117-24. Japanese. No abstract available.

PMID:
6471588
42.
43.

[Injections of urokinase into the pulmonary artery for the treatment of acute pulmonary embolism--evaluation of 3 cases].

Takahashi T, Ozasa K, Shibata T, Tanimura C, Uyama M, Nakagawa H, Inui T, Mineo T, Miyao K.

Kokyu To Junkan. 1983 Apr;31(4):451-6. Japanese. No abstract available.

PMID:
6346443
44.

[Evaluation of organ blood flow distribution in man by consecutive double dose Tl-201 scintigraphy--effect of dipyridamole and the application to diagnosis of ischemic heart disease--].

Sugihara H, Adachi H, Torii Y, Miyanaga H, Nishida K, Niki S, Yamada C, Kono Y, Furukawa K, Katsume H, Ijichi H, Miyao K.

Kaku Igaku. 1982 Jul;19(6):903-8. Japanese. No abstract available.

PMID:
7154410
45.

[Evaluation of the progress of aging based on specific biological age as estimated by various physiological functions (author's transl)].

Nakamura E, Kimura M, Nagata H, Miyao K, Ozeki T.

Nihon Eiseigaku Zasshi. 1982 Feb;36(6):853-62. Japanese. No abstract available.

PMID:
7087248
46.

Effect of consecutive dosing of thiamphenicol on its own serm concentration and liver drug metabolizing enzyme activities.

Ogo T, Shiojiri H, Kanazawa T, Sato M, Miyao K.

Jpn J Pharmacol. 1972 Jun;22(3):427-31. No abstract available.

47.

Changes in serotype of Pseudomonas aeruginosa.

Homma JY, Shionoya H, Yamada H, Enomoto M, Miyao K.

Jpn J Exp Med. 1972 Apr;42(2):171-2. No abstract available.

PMID:
4625367
48.

MOde of action of analgesic effect of 2-methylaminomethyl-2,3-dihydrobenzofuran (EPS-4032).

Ogo T, Kitahara A, Fujimoto M, Hirose N, Miyao K.

Chem Pharm Bull (Tokyo). 1971 Dec;19(12):2634-6. No abstract available.

PMID:
5145924
49.

[Analgesic effect of 2-methylaminoethyl 2,3-dihydrobenzofuran (EPS-4032); mode of action in mice].

Ogo T, Kitahara A, Fujimoto M, Miyao K.

Nihon Yakurigaku Zasshi. 1971 Nov;67(6):580-94. Japanese. No abstract available.

PMID:
5316822
50.

[Effect of a large dose of menaquinone-4 (K2) on the blood coagulation system in normal rabbits].

Tajima T, Ogo T, Miyao K.

Nihon Yakurigaku Zasshi. 1971 Sep;46(5):486-93. Japanese. No abstract available.

PMID:
5168895

Supplemental Content

Support Center